jtt 501 has been researched along with Body Weight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anai, M; Asano, T; Fukushima, Y; Funaki, M; Inukai, K; Ishihara, H; Katagiri, H; Kikuchi, M; Ogihara, T; Oka, Y; Onishi, Y; Sakoda, H; Shibata, T; Terasaki, J; Yazaki, Y | 1 |
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F | 1 |
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
3 other study(ies) available for jtt 501 and Body Weight
Article | Year |
---|---|
Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Cell Membrane; Cells, Cultured; Dietary Fats; Glucose Clamp Technique; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Isoxazoles; Kinetics; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 1998 |
Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Isoxazoles; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides | 1999 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |